Share

    


Home / Search Results

Search Results

Search Again?

Filter By Topic

You searched for:

New Molecular Entities JaypircaTM (pirtobrutinib) – Loxo/Lilly Oncology received approval for its novel BTK inhibitor as treatment of adult patients with relapsed or refractory mantle cell lymphoma (MCL) after at least two lines of systemic therapy (including treatment with another BTK inhibitor). The approval was based on response rates observed among 120 MCL patients who were treated with …
Cancer Drugs are Expensive: Recent policy approaches and pitfalls Samyukta Mullangi, MD MBA Medical Director of Oncology at Thyme Care Medical Oncologist at Tennessee Oncology The annual cost of cancer care is expected to approach $246B by 2030. Source: https://www.fightcancer.org/sites/default /files/National%20Documents/Costs-of-Cancer-2020- 10222020.pdf Launch …
CCMED_3_2_Infographic_May_29_2020 Improving care for patients with stage III/IV NSCLC: learnings for multidisciplinary teams from the ACCC national quality survey Salgia et al. (2020) What are the barriers to effective MDT implementation and how can MDTs be optimized for NSCLC treatment? What Are the Barriers to Efficient Multidisciplinary Treatment of Stage III/IV Non-Small …
A Comparative Report on Key Cancer DRGs Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=uacc20 Oncology Issues ISSN: 1046-3356 (Print) 2573-1777 (Online) Journal homepage: https://www.tandfonline.com/loi/uacc20 A Comparative Report on Key Cancer DRGs Lee E. Mortenson To cite this article: Lee E. Mortenson …
Lessons from Minnesota Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=uacc20 Oncology Issues ISSN: 1046-3356 (Print) 2573-1777 (Online) Journal homepage: https://www.tandfonline.com/loi/uacc20 Lessons from Minnesota Lee E. Mortenson To cite this article: Lee E. Mortenson (1995) Lessons from …
Metastatic Colon and Rectal Cancer Updates, ASCO 2022 Colorectal and Anal Cancer Justin Chau, MD Hematology, Oncology, and Blood & Marrow Transplantation University of Iowa Hospitals and Clinics Disclosures I have no disclosures to report. Permission was obtained from ASCO to use the following slides from its 2022 Annual Meeting in this presentation. What …
Figure6_FunctionalActivityStatus.indd Patient Name: ____________________________________________________ Date: _____________________________ Patient ID: ________________________________________________________ I am now going to ask you about several activities that people do from day to day. For each question, please respond with one of the following three choices: No help, …
The most important strategy to improve the Prior Authorization process is to have clear procedures and workflows. Below are a few tips on how to set up your workflows and improve reimbursement. ASSOCIATION OF COMMUNITY CANCER CENTERS Tips to Maximize Efficiency When Completing Prior Authorizations CAPTURE FRONT END MISTAKES EARLY • Improve pre-registration process • Capture correct …
Over half of patients newly diagnosed with multiple myeloma are not eligible for transplant due to age or other major health problems. Listen as Dr. Yee provides treatment planning options available to patients who are ineligible for transplant.
Tune-in as Dr. Hobbs discusses symptom scoring, risk stratification, and effective practices in building a strong myelofibrosis program.
CANCER BUZZ speaks with Susan Spinosa, president and patient founder of NTRKers, an organization created to support patients with NTRK fusion-positive cancer, about her care journey and the importance of testing for NTRK gene fusions.
Survey-Patient-Satisfaction-Fox-Chase
« 1 2 3 4 5 6 7 » Karmanos Cancer Institute/Wayne State University Detroit, Michigan The DISCO App: A Patient-Focused Tool to Reduce Financial Toxicity Lauren M. Hamel, PhD, Assistant Professor, Department of Oncology The DISCO (DIScussions of COst) app educates patients with cancer about potential treatment-related costs and generates tailored questions to prompt …
Learn more about how this health system is gleaning new insights into clinical workforce needs to optimize future staffing and scheduling decisions.
Explore state and federal resources to support cancer care providers in delivering the quality care their patients deserve.
Reviewers: Lu Anne, Sarah Sender: TACOS Target: TACOS Members Subject Line: Your April Oncology Newsletter Is Here! Pre-Header: Review April Drug Updates & Upcoming Meetings in Your State Link banner to: https://www.accc-cancer.org/state-societies/Arizona/tacos-homepage Your Oncology Newsletter: April 2024 edition has arrived! This monthly digital publication—a benefit of TACOS …
2024 ACCC Abstract Submissions The Association of Cancer Care Centers (ACCC) is now accepting abstracts for poster presentations and track sessions at the ACCC 41st National Oncology Conference, October 9-11, in Minneapolis, Minnesota. Priority will be given to posters and sessions that support the 2024-2025 ACCC President’s Theme: Reimagining Community Engagement and Equity in Cancer. Potential topics …
Policy Coverage and Prior Authorization Considerations for LYNPARZA® (olaparib) + Bevacizumab in the First-Line Maintenance Setting for Women With HRD-Positive Advanced Ovarian Cancer Please see additional Important Safety Information throughout and accompanying complete Prescribing Information, including Patient Information (Medication Guide). LYNPARZA in combination with bevacizumab was …
fast facts Biggest Concerns for Today’s Hospitals • Attracting talent: 26% • Retaining talent: 21% • Avoiding burnout: 19% • Controlling costs: 15% • Improving the patient experience: 9% • Scheduling providers: 9% Source. Locum Tenens.com. Innovation & Flexibility: Journey to Sustainable Healthcare Report. locumtenens.com/media/4qcd0yjs/innovation-flex-report.pdf. Analysis …